These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 8626357

  • 1. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM.
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF.
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [Abstract] [Full Text] [Related]

  • 8. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
    Sajatovic M, DiGiovanni S, Fuller M, Belton J, DeVega E, Marqua S, Liebling D.
    Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738
    [Abstract] [Full Text] [Related]

  • 11. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C, Schulberg HC, Shear MK.
    Anxiety; 1996 Apr; 2(5):210-8. PubMed ID: 9160625
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Apr; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 14. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Apr; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 15. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder.
    Taylor FB, Prather MR.
    Depress Anxiety; 2003 Jun; 18(2):83-8. PubMed ID: 12964175
    [Abstract] [Full Text] [Related]

  • 17. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 Jun; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 18. Efficacy in long-term treatment of depression.
    Montgomery SA.
    J Clin Psychiatry; 1996 Jun; 57 Suppl 2():24-30. PubMed ID: 8626360
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Jun; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 20. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET.
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.